BJ
PBYI icon

BlackRock Japan’s Puma Biotechnology PBYI Stock Holding History

BlackRock Japan’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$30K Buy
972
+385
+66% +$16.6K ﹤0.01% 1060
2016
Q3 		$39K Buy
587
+550
+1,486% +$27.8K ﹤0.01% 1019
2016
Q2 		$1K Buy
+37
New +$1.16K ﹤0.01% 1410
2015
Q4 		– Sell
-33,539
Closed -$2.53M – 1414
2015
Q3 		$2.53M Sell
33,539
-2,226
-6% -$211K 0.01% 663
2015
Q2 		$4.18M Buy
35,765
+34,203
+2,190% +$6.19M 0.02% 663
2015
Q1 		$369K Sell
1,562
-423
-21% -$90.4K ﹤0.01% 798
2014
Q4 		$376K Buy
1,985
+1,327
+202% +$294K ﹤0.01% 787
2014
Q3 		$157K Buy
658
+360
+121% +$73.9K ﹤0.01% 879
2014
Q2 		$20K Sell
298
-1,884
-86% -$134K ﹤0.01% 1152
2014
Q1 		$227K Buy
2,182
+887
+68% +$104K ﹤0.01% 912
2013
Q4 		$134K Buy
1,295
+919
+244% +$53.9K ﹤0.01% 978
2013
Q3 		$20K Buy
+376
New +$20.3K ﹤0.01% 1231

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BlackRock Japan's PBYI Position: Q4 2016 in Review

BlackRock Japan increased its Puma Biotechnology (PBYI) stake by 66% in Q4 2016, buying an estimated $16.6K and bringing the position to 972 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

BlackRock Japan first reported a position in PBYI in Q3 2013 and has held it in 12 quarters since. The position peaked at $4.18M in Q2 2015. 128 funds tracked by Wall St. Rank hold PBYI as of Q4 2016.

  • BlackRock Japan held 972 shares of Puma Biotechnology worth $30K as of Q4 2016.
  • BlackRock Japan bought 385 Puma Biotechnology shares in Q4 2016, an estimated $16.6K.
  • Puma Biotechnology made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1060 holding.
  • BlackRock Japan first reported a position in Puma Biotechnology in Q3 2013 and has held it in 12 quarters since.
  • BlackRock Japan's Puma Biotechnology position peaked at $4.18M in Q2 2015.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.